Spectrophotometric Method for the Estimation of Aciclovir in Bulk Drug
Abstract
Abstract
Aciclovir gives antiviral activity; one, new, simple, accurate, rapid, economical and precise procedure for spectrophotometric estimation of aciclovir in bulk drug. Aciclovir was estimated at 254 nm in 0.1 M sodium hydroxide, at 254 nm in 0.1 M hydrochloric acid, and at 254 nm in 7.4 phosphate buffers. The linearity range was found to be 5–30 µg/ml. The molar absorptivity was found to be 9.376x10 in 0.1 M sodium hydroxide, in 9.530x10 in 7.4 phosphate buffer and 9.481x10 in 0.1 M hydrochloric acid. The methods are validated and can be successfully applied to estimate aciclovir in pharmaceutical dosage forms.
Keywords: Aciclovir, bulk drug, UV spectrophotometry
Cite this Article
Shanmugam S, Valarmathi S, Ravichandran V et al. Spectrophotometric Method for the Estimation of Aciclovir in Bulk Drug. Research & Reviews: A Journal of Drug Design & Discovery. 2015; 2(3): 1–3p.
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information: Name: Address:
E-mail:
Contact Number: I
t is herein agreed that: The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.I/We also agree to the authorship of the article in the following order:Author(s) Name Signature(s)1. ________________2. ________________3. ________________4. ________________The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).
